Non-infected (–) and infected (+) Vero whole cell extracts were separated by gradient gel, and the membrane was blotted with Zika virus NS3 protein antibody (GTX133320) diluted at 1:2500.
Non-infected (–) and infected (+) Vero whole cell extracts were separated by gradient gel, and the membrane was blotted with Zika virus NS3 protein antibody (GTX133320) diluted at 1:2500.
Zika virus NS3 protein antibody
GTX133320
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
Product group Antibodies
ReactivityVirus
Overview
- SupplierGeneTex
- Product NameZika virus NS3 protein antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. ICC/IF: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.35 mg/ml
- ConjugateUnconjugated
- HostRabbit
- IsotypeIgG
- ReactivityVirus
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Tan Z, Wu J, Huang L, et al. LGP2 directly interacts with flavivirus NS5 RNA-dependent RNA polymerase and downregulates its pre-elongation activities. PLoS Pathog. 2023,19(9):e1011620. doi: 10.1371/journal.ppat.1011620Read this paper
- Riva L, Goellner S, Biering SB, et al. The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking De Novo Formation of the Membranous Replication Compartment. J Virol. 2021,95(22):e0099621. doi: 10.1128/JVI.00996-21Read this paper
- Shin HJ, Kim MH, Lee JY, et al. Structure-Based Virtual Screening: Identification of a Novel NS2B-NS3 Protease Inhibitor with Potent Antiviral Activity against Zika and Dengue Viruses. Microorganisms. 2021,9(3). doi: 10.3390/microorganisms9030545Read this paper
- Goellner S, Cerikan B, Cortese M, et al. Replication-Independent Generation and Morphological Analysis of Flavivirus Replication Organelles. STAR Protoc. 2020,1(3):100173. doi: 10.1016/j.xpro.2020.100173Read this paper
- Cui X, Zhou R, Huang C, et al. Identification of Theaflavin-3,3'-Digallate as a Novel Zika Virus Protease Inhibitor. Front Pharmacol. 2020,11:514313. doi: 10.3389/fphar.2020.514313Read this paper
- Cerikan B, Goellner S, Neufeldt CJ, et al. A Non-Replicative Role of the 3' Terminal Sequence of the Dengue Virus Genome in Membranous Replication Organelle Formation. Cell Rep. 2020,32(1):107859. doi: 10.1016/j.celrep.2020.107859Read this paper
- Luo H, Li G, Wang B, et al. Peli1 signaling blockade attenuates congenital zika syndrome. PLoS Pathog. 2020,16(6):e1008538. doi: 10.1371/journal.ppat.1008538Read this paper
- Whelan JN, Li Y, Silverman RH, et al. Zika Virus Production Is Resistant to RNase L Antiviral Activity. J Virol. 2019,93(16). doi: 10.1128/JVI.00313-19Read this paper